Jeffrey Stuart Bergman

Title: The Innovations of Jeffrey Stuart Bergman

Introduction

Jeffrey Stuart Bergman is a notable inventor based in Hertfordshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on transdermal drug delivery systems. His research and inventions have the potential to improve patient care and medication administration.

Latest Patents

Bergman holds a patent for the "Composition of dexibuprofen transdermal hydrogel." This stable non-alcoholic transdermal hydrogel of dexibuprofen was developed using a straightforward manufacturing process. Experimental trials indicated that the pH modifying agent, antioxidant, and water-miscible solvent are essential excipients for obtaining a stable formulation. The dexibuprofen hydrogel prepared with carbopol as a gelling polymer resulted in an opaque gel, while the hydrogel made with hydroxypropyl methylcellulose (HPMC) produced a transparent gel. Stability studies conducted at accelerated conditions (40°C/75% RH) for three months in laminated tubes showed no significant changes in physical description, pH, assay, or related substance values.

Career Highlights

Throughout his career, Bergman has worked with reputable companies such as Strides Shasun Limited and Strides Pharma Science Limited. His experience in these organizations has contributed to his expertise in pharmaceutical formulations and innovations.

Collaborations

Bergman has collaborated with professionals like Sampathkumar Devarajan and Selvakumar Ramalingam. These partnerships have likely enhanced his research and development efforts in the pharmaceutical industry.

Conclusion

Jeffrey Stuart Bergman is a distinguished inventor whose work on dexibuprofen transdermal hydrogel exemplifies innovation in drug delivery systems. His contributions to the field are noteworthy and have the potential to impact patient care positively.